Galera Therapeutics Seeks Strategic Alternatives Amid Financial Setbacks and Regulatory Challenges - MyChesCo
MALVERN, PA — Galera Therapeutics, Inc. (Nasdaq: GRTX), a key player in the pharmaceutical industry, recently unveiled its financial results for the fourth quarter and full year of 2023, which …
Timothy Alexander
